ストックスクリーナーアプリを入手
2.84
3.65%
0.10
アフターアワーズ：
2.84
前日終値:
$2.74
開ける：
$2.89
24時間の取引高:
35,406
Relative Volume:
3.62
時価総額：
$148.71M
収益：
$18.85M
当期純損益:
$-119.67M
株価収益率:
-1.078
EPS:
-2.6346
ネットキャッシュフロー:
$-89.09M
1週間 パフォーマンス:
+13.15%
1か月 パフォーマンス:
+30.88%
6か月 パフォーマンス:
+19.33%
1年 パフォーマンス:
-13.15%
1日の値動き範囲:
$2.74
$2.98
1週間の範囲:
$2.52
$2.98
52週間の値動き範囲:
$1.53
$4.50
Inventiva Adr Stock (IVA) Company Profile
IVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
2.84 | 148.71M | 18.85M | -119.67M | -89.09M | -2.6346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-21 | 開始されました | TD Cowen | Buy |
| 2024-11-12 | 開始されました | UBS | Neutral |
| 2023-10-27 | 開始されました | Canaccord Genuity | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-19 | アップグレード | Societe Generale | Sell → Buy |
| 2023-03-17 | 開始されました | Stifel | Buy |
| 2022-11-15 | ダウングレード | Societe Generale | Buy → Sell |
| 2021-03-08 | ダウングレード | Societe Generale | Buy → Sell |
| 2020-08-05 | 開始されました | ROTH Capital | Buy |
| 2020-08-04 | 開始されました | Guggenheim | Buy |
| 2020-08-04 | 開始されました | Stifel | Buy |
すべてを表示
Inventiva Adr (IVA) 最新ニュース
Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant dans l'étude de Phase 1 - GlobeNewswire Inc.
Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva
Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Inventiva ADR (IVA) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com
Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - Inventiva
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Yahoo Finance
NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - Inventiva
Will Election Commission Make Sure That Elections In 2024 Will Be Completely Fair? - Inventiva
Is SBI's Demand For Extra Time To Disclose Details Of Electoral Bonds 1 Attempt To Hide The Doings And Doers Of ‘Great Political Chanda’? - Inventiva
symbol__ Stock Quote Price and Forecast - CNN
National Parties Declare Assets Worth Rs 8,829 Crore In 2021-22: Report - Inventiva
Explosive Showdown: Rahul Yadav-Led 4B Networks Clash with Info Edge in High-Stakes Arbitration Battle - Inventiva
The Indian Chief Ministers Are A Bunch Of Crorepatis While The Average Middle-Class Indian Tax Payer Is Struggling To Survive - Inventiva
Top 10 Best Handicraft Companies In USA 2023 - Inventiva
Top 20 Best Hardware & Networking Company In India 2023 - Inventiva
Top 10 Best Law Firms In India 2023. - Inventiva
Top 10 Best LegalTech companies in India 2023 - Inventiva
An Interesting Telecom Startup Announced Funding Of INR 30 Crore - Inventiva
TCS, Infosys, Wipro Hire Over 1 Lakh Employees This Fiscal. Know Details - Inventiva
8 US equities have commenced trading on the NSE IFSC in GIFT City; All information about how to start trading through IFSC and should you put money in US stocks? - Inventiva
Innovation And Technology Revolutionizing The Legal Landscape In India 2022 - Inventiva
India Has Its First Most Awaited International Arbitration Centre In Hyderabad In 2021. - Inventiva
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance
Inventiva Adr (IVA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):